Endocrinological outcome following first time transsphenoidal surgery for GH-, ACTH-, and PRL-secreting pituitary adenomas

Acta Neurochirurgica

Volumn 144, Issue 6, 2002, Pages 555-561

  Kristof, R A ^a   Schramm, J ^a   Redel, L ^a   Neuloh, G ^a   Wichers, M ^a   Klingmuller D ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Acromegaly; Cushing's disease; Prolactinoma; Transsphenoidal surgery

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; PROLACTIN;

ADULT; ARTICLE; CONTROLLED STUDY; DATA BASE; DIABETES INSIPIDUS; FEMALE; FOLLOW UP; HORMONE RELEASE; HOSPITAL; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMISSION; SINUSITIS; STANDARDIZATION; STATISTICAL SIGNIFICANCE; TRANSSPHENOIDAL SURGERY; TREATMENT FAILURE; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; WATER METABOLISM;

ADRENOCORTICOTROPIC HORMONE; ADULT; ENDOCRINE SYSTEM; FEMALE; FOLLOW-UP STUDIES; GROWTH HORMONE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PITUITARY NEOPLASMS; PROLACTINOMA; SPHENOID BONE;

EID: 0036316693     PISSN: 00016268     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00701-002-0938-1     Document Type: Article

References (30)

1. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumours
2. The European Cushing's Disease Survey Study Group: Factors influencing the immediate and late outcome of Cushing's Disease treated by transsphenoidal surgery: A prospective study by the European Cushing's Disease Survey Group
3. Treatment of prolactinomas
4. Results of surgical treatment for growth hormonesecreting pituitary adenomas
5. Short-term preoperative treatment of macroprolactinomas by dopamine agonists
6. Evidence supporting surgery as treatment of choice for acromegaly. Panel discussion paper
7. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: Long term follow-up. Extensive personal experience
8. Surgical therapy of pituitary adenomas
9. Prevalence, predictors and patterns of postoperative polyuria and hyponatriaemia in the immediate course after transsphenoidal surgery for pituitary adenomas
10. Persistent and recurrent hypercortisolism after transsphenoidal surgery for Cushing's disease
11. Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease
12. Perivascular fibrosis in prolactinomas: Is it increased by bromocriptine?
13. Pituitary surgery for the management of acromegaly
14. Treatment results of acromegaly as analyzed by different criteria
15. Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 Years of follow-up
16. Acromegaly
17. Pathologic hyperprolactinemia
18. Long term results of transsphenoidal adenomectomy in patients with Cushing's disease
19. Pathophysiology of hyponatriaemia after transsphenoidal pituitary surgery
20. Prolactin secreting pituitary adenomas: Analysis of 429 surgically treated patients, effect of adjuvant treatment modalities and review of the literature
21. Surgical outcome and pathological effects of bromocriptine preoperative treatment in prolactinomas
22. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients
23. The posterior pituitary and water metabolism
24. Recurrence of hyperprolactinemia after selective transsphenoidal adenomectomy in women with prolactinoma
25. Acromegaly: Biochemical assessment of cure after long term follow-up of transsphenoidal selective adenomectomy
26. Risk factors and long-term outcome in pituitary-dependent Cushing's disease
27. The anterior pituitary
28. Trans-sphenoidal surgery for microprolactinoma: An acceptable alternative to dopamine agonists?
29. Transsphenoidal microsurgical therapy of prolactinomas: Initial outcomes and long-term results